An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants
Clinical trial NCT05013008 · COMPLETED
Trial details
- NCT number
- NCT05013008
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2021-12-31
- Enrollment
- 951
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.